Investors

investor people image

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Osiris Completes Enrollment in Stem Cell Trial to Treat Cardiac Disease
View HTML
Toggle Summary Osiris Stem Cell Funding Totals $70 Million for 2005
Additional $19 million in private equity concludes a successful year of stem cell development
View HTML
Toggle Summary Osiris Receives Orphan Drug Status from FDA for Lead Stem Cell Drug
View HTML
Toggle Summary Osiris Cleared by FDA to Begin Phase II Stem Cell Trial for the Treatment of Crohn's Disease
View HTML
Toggle Summary Osiris Reaches Safety Milestone in Stem Cell Clinical Trial for Cardiac Patients
View HTML
Toggle Summary Stem Cell Drug Saves Baby From Blood Disorder View HTML
Toggle Summary New Stem Cell Drug Gives baby Second Chance View HTML
Toggle Summary New stem cell treatment being evaluated for critically ill bone marrow transplant patients
Osiris Launches a Phase II Clinical Trial for Severe Graft vs Host Disease
View HTML
Toggle Summary Osiris Launches the Osteocel Product Line
Bone repair product provides a much needed option for orthopedic surgery
View HTML
Toggle Summary Osiris and JCR Pharmaceuticals Reach Milestone, Expand License Agreement
Companies to expand stem cell technology into a new market opportunity
View HTML